Hinge Health, Inc. cash flow to debt ratio of 2.13K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Hinge Health, Inc.'s free cash flow has increased 277.49% from $45.23M last year to $170.73M, signaling increasing performance

Hinge Health, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability.

Hinge Health, Inc.'s debt has decreased relative to shareholder equity from 0.03 last year to 0.02 today, signaling strengthened financials

Hinge Health, Inc. has a net cash position, so leverage is healthy.

Interest expense is not separately reported in Hinge Health, Inc.'s latest filing, so interest coverage cannot be calculated.

Hinge Health, Inc.'s profit margin has increased (-595.56%) in the last year from -3.06% to 15.15%, signaling increasing performance

Hinge Health, Inc.'s short-term assets of $533.90M exceed its short-term liabilities of $362.41M

Hinge Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Hinge Health, Inc.'s return on equity of 30.25%, is higher than 15.00%, indicating good performance

Hinge Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Hinge Health, Inc. has insufficient public price history to evaluate earnings stability.

Hinge Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Hinge Health, Inc. has a free cash flow yield of 2.41%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Hinge Health, Inc.'s yearly earnings has decreased 4.33K% since last year from $-11.93M to $-528.26M, signaling decreasing performance

Hinge Health, Inc.'s yearly revenue has increased 50.58% since last year from $390.40M to $587.86M, signaling increasing performance

ROIC 26.29% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Hinge Health, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Hinge Health, Inc. has insufficient public price history to evaluate revenue consistency.

Hinge Health, Inc. has insufficient public price history to evaluate ROE consistency.

Hinge Health, Inc. has insufficient data to evaluate this check.

Hinge Health, Inc. has an earnings yield of 1.51%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Hinge Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Hinge Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Hinge Health, Inc. has insufficient data to evaluate this check.

Hinge Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Hinge Health, Inc. has a price-to-book ratio of 20.95x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Hinge Health, Inc. has a price-to-sales ratio of 10.02x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue